期刊文献+

膀胱移行细胞癌VEGF的表达及其意义 被引量:8

Expression of VEGF in transitional cell carcinoma of bladder and its significance
下载PDF
导出
摘要 目的:探讨VEGF在膀胱移行细胞癌(BTCC)中的表达及其与BTCC生物学行为的关系。方法用流式细胞技术(FCM)对40例BTCC和20例正常膀胱黏膜细胞组织标本进行VEGF阳性细胞检测。结果BTCC组织中VEGF阳性细胞比率为(34.50±15.57)%,在正常膀胱黏膜组织中的VEGF阳性细胞比率为(13.30±6.23)%,两者比较差异有统计学意义(P<0.01);临床分期Tis^T1为(27.07±10.76)%,T2~T4为(48.29±13.77)%,病理分级Ⅰ级为(22.4±38.15)%,Ⅱ级为(35.01±9.95)%,Ⅲ级为(53.09±12.39)%;随着分期分级的增加,VEGF的表达率也逐步增加,差异有统计学意义(P<0.01)。结论VEGF定量分析可作为BTCC的生物学行为评估方法之一。 Objective To investigate the quantitative expression of VEGF in transitional cell carcinoma of bladder and to evaluate the relationship between VEGF and the biological behavior of transitional cell carcinoma, of bladder (BTCC). Methods Samples of tumor and normal mucosa were taken from 40 patients and 20 cases of normal bladder tissue respectively. The percentage of VEGF positive cells in these samples were examined by flow cytometry. Results The percentage of VEGF positive cells was (34.50 ± 15.57) 96 in tumor tissue and (13.30 ± 6.23) % in normal tissue (P〈0.01). The positive cells were noted in (27.7 ± 10.76) % of Tis--T1 and (48.29 ± 13.77) % of T2--T4, and (22.43±8.15)% orgy, (35.01±9.95)% of G2, and (53.09±12.39)% of G3 tumor tissue. With the progression of clinical stage and grade, the positive rate of VEGF expression increased ( P 〈 0.01 ). Conclusions Quantitative examination of VEGF expression can be one method to evaluate the biological behavior of BTCC.
出处 《实用临床医药杂志》 CAS 2009年第3期41-43,共3页 Journal of Clinical Medicine in Practice
关键词 膀胱肿瘤 VEGF 流式细胞术 bladder neoplasms VEGF flow cytometry
  • 相关文献

参考文献15

  • 1Ferrara N,Henzel W J.Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells[J].Biochem Biophys Res Commun,1989,161:851.
  • 2Yuan A,Yu C J,Chen W J,et al.Correlation of total VEGF mRNA and protein expression with histologic type,tumor angiogenesis,patient survival and timing of relapse in non-small cell lung cancer[J].Int J Cancer,2000,89(6):475.
  • 3Jone A.Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression[J].Urol Clin North Am,2000,27:791.
  • 4Crew J P.Vascular endothelial growth factor an important angiogenic in bladder cancer[J].Eur Urol,1999,35(1):2.
  • 5Le L H,Chetty P,Moore M J.Epidermal growth factor receptor expression in aral canal carcinoma[J].Amarican Journal of Clinical Pathology,2005,124(1):20.
  • 6Deroanne C F,Hajiton A,Claire,et al.Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up regulation of vascular endothelial growth factor express[J].Cancer Res,1997,57:5590.
  • 7Takahashi H,Shibuya M,The vascular endothelial growth factor(VEGR)/VEGR receptor system and its role under physiological and pathological conditions[J].Clin Sci(Lond),2005,109(3):227.
  • 8Olsson A K,dimberg A,Kreuger J,et al.VEGF receptor signaling-in control of vascular function[J].Nat Rev Mol Cell Biol,2006,7:359.
  • 9LeCouter J,Moritz D R,Li B,et al.Angiogenesis-independent endothelial protection of liver:role of VEGFR-1[J].Science,2003,299:890.
  • 10阎洪涛,龚百生,廖勇,杨红,陈照祥.膀胱移行细胞癌组织中p53和血管内皮生长因子表达的关系及临床意义[J].中华泌尿外科杂志,2006,27(3):178-180. 被引量:12

二级参考文献15

  • 1许天文,陈道达,陈剑英.Expression of Vascular Endothelial Growth Factor C and Its Correlation with Lymph Node Metastasis in Colorectal Carcinoma[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2004,24(6):596-598. 被引量:9
  • 2白向阳,倪剑锋,吕安国,吴文芳,牛瑞芳.杀伤血管内皮生长因子受体1阳性细胞的靶向毒素[J].生物化学与生物物理进展,2005,32(4):365-370. 被引量:3
  • 3Levine AJ,Momand J,Finlay CA.The p53 tumor suppressor gene.Nature,1991,351:453-456.
  • 4Ferrara N,Chen H,Davis -Smyth T,et al.Vascular endothelial growth factor is essential for corpus luteum angiogenesis.Nature Med,1998,4:336-340.
  • 5O ' Brien T,Cranston D,Fuggle S,et al.Different angiogenic pathways characterize superficial and invasive bladder cancer.Cancer Res,1995,55:510-513.
  • 6Linderholm B,Lindh B,Tavelin B,et al.p53 and vascular-endothelial-growth-factor (VEGF)expression predicts outcome in 833 patients with primary breast carcinoma .Int J Cancer,2000,89:51-62.
  • 7Linderholm BK,Lindahl T,Holmberg L,et al.The expression of vasculor endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.Cancer Res,2001,61:2256-2260.
  • 8Dameron KM,volpert OV,Tainsky MA,et al.Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.Science,1994,265:1582-1584.
  • 9Giatromanolaki A,koukourakis MI,kakolyris S,et al.Vascular endothelial growth factor,with -type p53,and angiogenesis in early operable non -small cell lung cancer.Clin Cancer Res,1998,4:3017-3024.
  • 10Bouvet M,Ellis LM,Nishizaki M,et al.Adenovirus -mediated wildtype p53 gene transfer down -regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.Cancer Res,1998,58:2288-2292.

共引文献24

同被引文献69

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部